News
Nutriband Discloses $8.4M Private Placement Representing 2.10M Shares Of Common Stock At $4 Per Share; Company Targets 505(b)(2) NDA To FDA For Marketing Approval Of AVERSA Fentanyl In Q1 2025
19 Apr 24
News
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
28 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
27 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Wednesday's Intraday Session
27 Mar 24
Movers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
27 Mar 24
Movers
Nutriband Provided An Overview Of The Clinical Development And Regulatory Pathway For Its Lead Product, Aversa Fentanyl, An Abuse-deterrent Fentanyl Transdermal Patch
27 Mar 24
News, Health Care, General
12 Health Care Stocks Moving In Friday's After-Market Session
22 Mar 24
Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
22 Mar 24
Movers
Press releases
Nutriband Inc. Announces $8.4M Private Placement
19 Apr 24
Legal, Press Releases
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
27 Mar 24
News, Press Releases
Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting
4 Mar 24
News, Press Releases